Castle Biosciences Inc
CSTL
$32.91+0.80%
Delayed · as of Sep 7, 2026, 10:01 AM ET
Mkt cap
$570.23M
EV/Sales
1.35
P/E ratio
N/A
FY2025 Revenue
$344.23M
EPS (TTM)
$-0.64
Gross Margin (FY2025)
79.37%
Profit Margin (FY2025)
-7.02%
Beta
1.04
Div yield
N/A
Sector
Healthcare
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Latest reported CSTL revenue for 2025-12-31 was $344.2M. Net income was -$24.2M. Revenue was up 3.7% from 2024-12-31 to 2025-12-31. CSTL currently screens at market cap $570.2M.
Use this CSTL research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CSTL income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Castle Biosciences Inc (CSTL) is a diagnostics & research company in the Healthcare sector.
Latest cached Castle Biosciences Inc (CSTL) revenue for Dec 31, 2025 was $344.2M. Net income was -$24.2M. Statements: https://lician.com/financials/cstl
Castle Biosciences Inc (CSTL) market capitalization is $570.2M on the latest cached snapshot.
Castle Biosciences Inc (CSTL) cached previous close $32.65; day range $31.99 – $33.21; volume 187,725. Session quote: https://lician.com/quote/cstl
Castle Biosciences Inc (CSTL) latest cached earnings event is "CSTL earnings" on Aug 3, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CSTL filing is 8-K · Jan 13, 2026. Filings: https://lician.com/sec/cstl